Malaria News and Research

Latest Malaria News and Research

Antigenics awarded $424,720 grant under QTDP program

Antigenics Inc. today announced that it has been awarded $424,720 in grants under the IRS' Qualifying Therapeutic Discovery Project (QTDP) program. The grants were awarded in recognition of our two qualifying programs: AG-707, a phase 1 therapeutic vaccine for the treatment of genital herpes and QS-21 Stimulon® adjuvant.

4 Nov 2010

Experts develop tools to educate people about health risks associated with global travel

More than 30 million people in the United States travel to resource-limited areas of the world each year. This global mobility may contribute to the spread of infectious diseases such as influenza, measles, and meningitis and may also put individual travelers at risk for malaria, typhoid, dengue fever and hepatitis.

4 Nov 2010

Cempra to present information on solithromycin antimalarial agent at Atlanta Annual Meeting

Cempra Pharmaceuticals today announced abstracts to be presented on its novel fluoroketolide antibiotic, solithromycin (CEM-101), at the American Society of Tropical Medicine and Hygiene 59th Annual Meeting, November 3 to 7 in Atlanta. The abstracts will present new information on solithromycin's antimalarial activity. Additional data will demonstrate activity against Mycobacterium leprae.

4 Nov 2010

Alnylam third quarter revenue increases from $24.2 million to $27.7 million

Alnylam Pharmaceuticals, Inc. a leading RNAi therapeutics company, today reported its consolidated financial results for the third quarter ended September 30, 2010, and company highlights.

4 Nov 2010

Immune Network to complete patient enrollment in Phase 2b imm01 trial for tuberculosis

Immune Network Ltd. a company in the business of discovery and development of immune-based therapies, today announced that patient enrollment will be completed next week for the company's future partner Immunitor's Phase 2b imm01 trial of V5 immunotherapy in 120 patients with tuberculosis.

3 Nov 2010

GenVec receives $244,479 grant under QTDP program

GenVec, Inc. announced today that it was awarded a cash grant of approximately $244,479 under the U.S. Government's Qualifying Therapeutic Discovery Project program.

3 Nov 2010

New global map shows distribution of sickle cell gene

At a global scale, the sickle cell gene is most commonly found in areas with historically high levels of malaria, adding geographical support to the hypothesis that the gene, whilst potentially deadly, avoids disappearing through natural selection by providing protection against malaria.

3 Nov 2010

Guardian's Katine project coverage concludes

The Guardian concluded its three-year Katine project in north-eastern Uganda, which "tracked the implementation of a development project focusing on five aspects of deprivation: health, education, water and sanitation, livelihoods and governance," the newspaper writes.

3 Nov 2010

Advanced Life Sciences enters CRADA for Restanza with Walter Reed Army Institute of Research

Advanced Life Sciences Holdings, Inc., a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, oncology and respiratory diseases, today announced that it has entered into a Cooperative Research and Development Agreement ("CRADA") with The Walter Reed Army Institute of Research.

2 Nov 2010

VaxInnate’s prototype flu vaccine named as Top 10 Infectious Diseases Projects to Watch in 2011

VaxInnate Corporation announced today that VAX125, its investigational prototype vaccine for seasonal flu, has been named one of the Top 10 Infectious Diseases Projects to Watch in 2011 by Elsevier Business Intelligence and the Windhover Conferences.

2 Nov 2010

PPACA program provides $733,438 grant to Inovio

Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that it has received a $733,438 grant under The Patient Protection and Affordable Care Act of 2010 (PPACA).

2 Nov 2010

White House Health Advisor Emanuel visits U.S. government-funded health programs during 3-nation African trip

The global fight against malaria could cut prevalence rates of malaria to one in 20 fevers by 2017, Special Advisor on Health Policy to the Director of the White House Office of Management and Budget Ezekiel Emanuel said in an interview in Dakar, Senegal, Bloomberg reports.

2 Nov 2010

IRIN examines debate over malaria control versus eradication

After the recent publication of the Lancet series on malaria eradication, IRIN examines the debate over control versus eradication, stating the findings of some of the studies.

2 Nov 2010

Mechanism of rogue cell killer discovered

A team of Melbourne and London researchers have shown how a protein called perforin punches holes in, and kills, rogue cells in our bodies. Their discovery of the mechanism of this assassin is published today in the science journal Nature.

1 Nov 2010

Scientists use electron microscopes to study mechanism of perforin protein to punch holes in rogue cells

Scientists from the UK and Australia have seen the human immune system's assassin a protein called perforin in action for the first time. The UK team, funded by the Biotechnology and Biological Sciences Research Council (BBSRC) and the Wellcome Trust, is based at Birkbeck College where they used powerful electron microscopes to study the mechanism that perforin uses to punch holes in rogue cells.

1 Nov 2010

Killer malaria to disappear in 10-15 years: Experts

From data gathered around the world experts predict that the deadliest type of malaria can be eradicated in 10 to 15 years. The disease affects half the global population and kills an estimated 1.2 million people worldwide every year. The organism responsible for deaths is commonly Plasmodium falciparum. The parasite is at its most deadly in sub-Saharan Africa, where 90 per cent of malaria fatalities occur.

31 Oct 2010

Proteins to punch holes in cancer cells to kill them: Study

In a medical breakthrough scientists have found a protein called perforin that kills rogue cells in the human body especially the ones causing cancer. The team comprising of experts from Melbourne and London found that perforin punches holes and kills these cells. The research appeared in the acclaimed journal Nature.

31 Oct 2010

Progress made in universal access to HIV prevention, treatment and care under threat

A report issued today by the International AIDS Society, Universal Access: Right Here, Right Now documents the principal debates around universal access during the XVIII International AIDS Conference (AIDS 2010). The report also takes stock of progress to date and reveals the scale of the future challenge for HIV treatment and prevention at a time when new infections are outstripping those receiving treatment by five to two.

30 Oct 2010

Lancet series examines malaria eradication goal

Eliminating malaria can be achieved only with repeated investment over the long term and will require a major shift in policy and funding, according to some experts, Reuters reports.

30 Oct 2010

Recent releases in Global Health

Global Fund Will Make 'Every Possible Effort' To Raise Additional Resources: Although pledges to the Global Fund to Fight AIDS, Tuberculosis and Malaria at its recent replenishment meeting did not meet "the lowest estimate of demand," the Fund "will make every possible effort to raise the additional resources that we expect countries to request in the years ahead" through new donor recruitment and "innovative financing approaches," writes Executive Director Michael Kazatchkine in a Lancet comment

30 Oct 2010

Malaria News and Research

Latest Malaria News and Research

Antigenics awarded $424,720 grant under QTDP program

Experts develop tools to educate people about health risks associated with global travel

Cempra to present information on solithromycin antimalarial agent at Atlanta Annual Meeting

Alnylam third quarter revenue increases from $24.2 million to $27.7 million

Immune Network to complete patient enrollment in Phase 2b imm01 trial for tuberculosis

GenVec receives $244,479 grant under QTDP program

New global map shows distribution of sickle cell gene

Guardian's Katine project coverage concludes

Advanced Life Sciences enters CRADA for Restanza with Walter Reed Army Institute of Research

VaxInnate’s prototype flu vaccine named as Top 10 Infectious Diseases Projects to Watch in 2011

PPACA program provides $733,438 grant to Inovio

White House Health Advisor Emanuel visits U.S. government-funded health programs during 3-nation African trip

IRIN examines debate over malaria control versus eradication

Mechanism of rogue cell killer discovered

Scientists use electron microscopes to study mechanism of perforin protein to punch holes in rogue cells

Killer malaria to disappear in 10-15 years: Experts

Proteins to punch holes in cancer cells to kill them: Study

Progress made in universal access to HIV prevention, treatment and care under threat

Lancet series examines malaria eradication goal

Recent releases in Global Health

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Malaria News and Research

Latest Malaria News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in